|
Nov 30, 1999
Croatia: Starting a New Screening Program from Scratch
Trudy Oliver
USA
Trudy Oliver
Speaker of: Croatia: Starting a New Screening Program from Scratch
Dr. Oliver received her PhD from Duke University in 2005 in Pharmacology and Cancer Biology as a graduate student in Dr. Rob Wechsler-Reya's lab. She completed a Postdoctoral Fellowship (2006-2011) in Dr. Tyler Jack's lab at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT), Boston, MA. Dr. Oliver joined the University of Utah and Huntsman Cancer Institute in 2011. She is now Associate Professor with tenure and a Huntsman Cancer Institute (HCI) Endowed Chair in Cancer Research in the Department of Oncological Sciences. Dr. Oliver is a co-leader of the Cell Response and Regulation (CRR) and co-leader of the Lung Cancer Disease Center at HCI. Dr. Oliver has received many awards including a National Science Foundation (NSF) graduate student fellowship, and two postdoctoral fellowships from ASPET-Merck and the Ludwig Foundation at MIT. As an independent investigator, she has received awards from the Damon Runyon Cancer Research Foundation, the V Foundation for Cancer Research, American Cancer Society, American Lung Association, and was honored with a William C. Rippe Award for Distinguished Research in Lung Cancer from the Lung Cancer Research Foundation (LCRF).
Research: Dr. Oliver's research is devoted to understanding mechanisms of lung cancer biology with the goal of identifying novel therapeutic targets to improve patient outcome. As a graduate student at Duke, she studied the developmental origins of the childhood brain tumor, medulloblastoma, where she identified mechanisms of tumor progression in mouse models of the disease. As a postdoctoral fellow at MIT and as an independent investigator, she has developed novel mouse models of squamous and small cell lung cancer. Her work has contributed to our understanding of the Mdm2/p53 pathway, chemotherapy resistance mechanisms, and the functions of oncogenic transcription factors like Sox2, Nkx2-1, and Myc. Dr. Oliver’s laboratory integrates mouse genetics, molecular and cellular biology, biochemistry, single cell genomics, in vivo imaging, and preclinical therapeutics.
Teaching and Mentoring: Dr. Oliver has been active in graduate student and medical school teaching. Dr. Oliver's trainees have received a number of prestigious awards. These include the Susan Cooper Jones Postdoc of the Year Award, the James W. Prahl Memorial Graduate Student of the Year award, an NIH NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award. In addition, Oliver lab trainees have won a number of travel awards including to Keystone Symposia and selection as a recipient to the 68th Annual Lindau Nobel Laureate meeting in Germany.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.
Recent Episodes
Nov 01, 2025
Nov 23, 2024
Nov 21, 2023
Nov 30, 1999
David MacPherson
Nov 30, 1999
Kate Sutherland
Nov 30, 1999
Portia Thomas
Nov 30, 1999
Simon Heeke
Nov 30, 1999
Bruno Paiva
Nov 30, 1999
Catherine Meador
Nov 30, 1999
Carmen Garrido
Nov 30, 1999
Heather Wakelee
